Biotechnology analyst report: Undervalued biotechnology stock with potential to double: Pick 1 (Biotechnology analyst report: Undervalued biotechnology ... with potential to double) (English Edition)

This is our first stock pick in the planned series of analyst reports on undervalued biotechnology stocks trading below $10-15 with potential to double in the next 3-4 years. Each report is 3-4 pages long and written by Dr. Bhavneesh Sharma, MD, MBA (Finance, NYU). The report contains a discounted cash flow evaluation of the Company with an analyst estimate of the fair value per share.